We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Regent Pacific Group Limited, a specialist healthcare, wellness and life sciences investment group is pleased to announce that Fortacin™, the Group's prescription treatment for PE, went on sale in Hong Kong, S.A.R., China this January and will launch in